Issue of Equity
October 07 2009 - 1:00AM
UK Regulatory
TIDMMEDG
Medgenics, Inc.
('Medgenics' or the 'Company')
Issue of Equity
7 October 2009
The Company announces that on 6 October 2009 it completed a private placing to
raise GBP265,200 and a Board resolution was passed to issue and allot 4,420,000
common shares of US $0.0001 par value each ("Common Shares") conditional upon
admission to trading on AIM. The new Common Shares were issued at a price of 6
pence per Common Share. Application has now been made to the London Stock
Exchange for the New Common Shares to be admitted to trading on AIM. Dealings
are expected to commence at 8.00 a.m. on 12 October 2009.
Following the admission to trading of the new Common Shares, the Company's total
issued share capital will be 122,174,028* Common Shares of US $0.0001 each, the
percentage of AIM Securities not in public hands will be 29.4%*.
Note
* Excluding any Common Shares issued pursuant to the block admission between 4
June 2009 and the date of this announcement.
For further information, contact:
Medgenics, Inc. +972 4 902 8900
Dr. Andrew L. Pearlman
Grayling (Public Relations) +44 207 638 9571
Dr. Mark Swallow
Jonathan Shillington (Global Consulting Group)
Blomfield Corporate Finance (Nomad) +44 207 489 4500
James Pinner
Alan MacKenzie
SVS Securities plc (Broker) +44 207 638 5600
Peter Manfield or
Ian Callaway
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Medgenics(Regs) (London Stock Exchange): 0 recent articles
More Medgenics(Regs) News Articles